Overcoming Resistance Against HER2-Targeting Agents in...

Clinical Breast Cancer 2014 / 02 Vol. 14; Iss. 1

Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?

Huemer, Florian, Gampenrieder, Simon Peter, Schlattau, Alexander, Greil, Richard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2013.09.009
Date:
February, 2014
File:
PDF, 498 KB
english, 2014
Conversion to is in progress
Conversion to is failed